Martin Bauer's PRM Holdings unit has contributed to a round that will help Syqe expand use of its medical cannabis inhaler to other substances.

Israel-based medical cannabis inhaler provider Syqe Medical has received $50m in funding from investors including PRM Holdings, a subsidiary of botanical product supplier Martin Bauer Group, Globes has reported. The round was led by private equity firm Shavit Capital and also featured crowdfunding platform OurCrowd. Founded in 2011, Syge has developed a smart vaporiser that…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.